The Beauty Health Company (NASDAQ:SKIN) Stock Has Consensus Price Target of $1.38 According to Analysts

Shares of The Beauty Health Company (NASDAQ:SKIN) have earned a consensus rating of “Hold” from the seven brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $1.38.

SKIN has been the subject of several recent analyst reports. Weiss Ratings lowered Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, July 23rd. TD Cowen lowered their target price on shares of Beauty Health from $1.00 to $0.90 and set a “hold” rating on the stock in a research note on Wednesday, August 12th. Finally, Zacks Research lowered shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 20th.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Bank of America Corp DE increased its position in Beauty Health by 19.2% during the 1st quarter. Bank of America Corp DE now owns 106,242 shares of the company’s stock worth $95,000 after purchasing an additional 17,088 shares in the last quarter. Diversified Trust Co acquired a new position in Beauty Health during the first quarter valued at approximately $25,000. Renaissance Technologies LLC lifted its position in Beauty Health by 29.6% during the first quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock valued at $253,000 after buying an additional 64,900 shares in the last quarter. Finally, Capricorn Fund Managers Ltd purchased a new stake in Beauty Health during the first quarter worth approximately $17,270,000. 93.26% of the stock is currently owned by institutional investors.

Beauty Health Trading Down 4.8%

NASDAQ:SKIN opened at $0.60 on Friday. The company has a debt-to-equity ratio of 4.36, a current ratio of 1.76 and a quick ratio of 1.48. The firm has a 50-day moving average of $0.67 and a 200-day moving average of $0.76. The company has a market cap of $78.08 million, a PE ratio of -2.73 and a beta of 1.05. Beauty Health has a one year low of $0.55 and a one year high of $1.76.

Beauty Health (NASDAQ:SKIN) last announced its quarterly earnings data on Thursday, August 6th. The company reported ($0.02) EPS for the quarter, hitting the consensus estimate of ($0.02). Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. The business had revenue of $72.11 million for the quarter, compared to analyst estimates of $74.45 million. As a group, equities research analysts expect that Beauty Health will post -0.16 EPS for the current fiscal year.

About Beauty Health

BeautyHealth is a global health and beauty company focused on creating technology-enabled products and experiences for skin health. Its primary brand is Hydrafacial, which offers non-invasive skin treatments that combine cleansing, exfoliation, extraction and hydration with professional-grade devices, serums and treatment boosters.

The company also provides products and systems designed for complementary aesthetic and wellness applications, including Syndeo, a connected Hydrafacial delivery system; Keravive, a scalp-health treatment; and SkinStylus, a microneedling platform.